SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-051143
Filing Date
2021-10-01
Accepted
2021-10-01 16:46:10
Documents
14
Period of Report
2021-10-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea148280-8k_inmedphar.htm   iXBRL 8-K 27819
2 SEDAR FILING SUBMITTED OCTOBER 1, 2021 ea148280ex99-1_inmedpharm.htm EX-99.1 7145
6 GRAPHIC ex99-1_001.jpg GRAPHIC 5712
  Complete submission text file 0001213900-21-051143.txt   217285

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inm-20211001.xsd EX-101.SCH 3031
4 XBRL LABEL FILE inm-20211001_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE inm-20211001_pre.xml EX-101.PRE 22364
7 EXTRACTED XBRL INSTANCE DOCUMENT ea148280-8k_inmedphar_htm.xml XML 3613
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 211299535
SIC: 2834 Pharmaceutical Preparations